Sharon Bio-Medicine standalone net profit declines 11.84% in the December 2021 quarter
Sales decline 2.24% to Rs 42.81 crore
Net profit of Sharon Bio-Medicine declined 11.84% to Rs 4.02 crore in the quarter ended December 2021 as against Rs 4.56 crore during the previous quarter ended December 2020. Sales declined 2.24% to Rs 42.81 crore in the quarter ended December 2021 as against Rs 43.79 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales42.8143.79 -2 OPM %14.8114.87 -PBDT6.877.47 -8 PBT4.024.56 -12 NP4.024.56 -12Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content